Frequencies of glycophorin variants and alloantibodies against Hil and MINY antigens in Japanese.

MNS blood group Miltenberger phenotype glycophorin gene glycophorin variant

Journal

Vox sanguinis
ISSN: 1423-0410
Titre abrégé: Vox Sang
Pays: England
ID NLM: 0413606

Informations de publication

Date de publication:
Jan 2022
Historique:
revised: 08 04 2021
received: 01 03 2021
accepted: 11 04 2021
pubmed: 7 7 2021
medline: 13 1 2022
entrez: 6 7 2021
Statut: ppublish

Résumé

Antigens of the MNS blood group system are expressed on the red blood cell (RBC) membrane on glycophorin A (GPA) and glycophorin B (GPB) or on hybrid molecules of GPA and GPB. This study investigated the distribution of glycophorin variants and alloantibodies against Hil and MINY among Japanese individuals. Mi(a+) or Hil+ RBCs were screened using an automated blood grouping machine (PK7300) with monoclonal anti-Mi The GP.HF, GP.Mur, GP.Hut, GP.Vw, GP.Kip and GP.Bun frequencies in 1 005 594 individuals were 0·0357%, 0·0256%, 0·0181%, 0·0017%, 0·0009% and 0·0007%, respectively. GP.Hil was found in as four of the 13 546 individuals (0·0295%). Of 137 370 donors, 10 had anti-Hil (0·0073%) and three had anti-MINY (0·0022%). Glycophorin variants were relatively rare in Japanese individuals, with the major variants being GP.HF (0·0357%), GP.Hil (0·0295%) and GP.Mur (0·0256%). Only one example of anti-MINY was previously reported, but we found three more in this study.

Sections du résumé

BACKGROUND AND OBJECTIVES OBJECTIVE
Antigens of the MNS blood group system are expressed on the red blood cell (RBC) membrane on glycophorin A (GPA) and glycophorin B (GPB) or on hybrid molecules of GPA and GPB. This study investigated the distribution of glycophorin variants and alloantibodies against Hil and MINY among Japanese individuals.
METHODS METHODS
Mi(a+) or Hil+ RBCs were screened using an automated blood grouping machine (PK7300) with monoclonal anti-Mi
RESULTS RESULTS
The GP.HF, GP.Mur, GP.Hut, GP.Vw, GP.Kip and GP.Bun frequencies in 1 005 594 individuals were 0·0357%, 0·0256%, 0·0181%, 0·0017%, 0·0009% and 0·0007%, respectively. GP.Hil was found in as four of the 13 546 individuals (0·0295%). Of 137 370 donors, 10 had anti-Hil (0·0073%) and three had anti-MINY (0·0022%).
CONCLUSIONS CONCLUSIONS
Glycophorin variants were relatively rare in Japanese individuals, with the major variants being GP.HF (0·0357%), GP.Hil (0·0295%) and GP.Mur (0·0256%). Only one example of anti-MINY was previously reported, but we found three more in this study.

Identifiants

pubmed: 34227688
doi: 10.1111/vox.13121
doi:

Substances chimiques

Glycophorins 0
Isoantibodies 0
MNSs Blood-Group System 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

94-98

Informations de copyright

© 2021 International Society of Blood Transfusion.

Références

The International Society of Blood Transfusion. Red cell immunogenetics and Blood Group Terminology Working Party. http://www.isbtweb.org/fileadmin/user-upload/Working-parties/WP-on-Red-Cell-Immunogenetics-and/Table-of-blood-group-antigens-within-systems-v8.1-181111.pdf. Accessed 24 June 2021.
Tippet P, Reid ME, Poole J, Green CA, Daniels GL, Anstee DJ. The Miltenberger subsystems: is it obsolescent? Transfus Med Rev. 1992;6:170-82.
Dahr W. Miltenberger subsystem of the MNSs blood group system. Review and outlook. Vox Sang. 1992;62:129-35.
Johe KK, Vengelen-Tyler V, Leger R, Blumenfeld OO. Synthetic peptides homologous to human glycophorins of the Miltenberger complex variants of MNSs blood group system specify the epitopes for Hil, SJL, Hop, and Mur antisera. Blood. 1991;78:2456-61.
Heathcote D, Carroll T, Wang JJ, Flower R, Rodionov I, Tuzikov A, et al. Novel antibody screening cells, MUT+Mur kodecytes, created by attaching peptides onto red blood cells. Transfusion. 2010;50:635-41.
Reid ME, Poole J, Green C, Neill G, Banks J. MINY: a novel MNS-related blood group antigen. Vox Sang. 1992;63:129-32.
Lopez GH, Wei L, Ji Y, Condon JA, Luo G, Hyland CA, et al. GYP*Kip, a novel GYP(B-A-B) hybrid allele, encoding the MNS48 (KIPP) antigen. Transfusion. 2016;56:539-41.
Daniels Geoff. MNS Blood Group System. Human Blood Groups. 3rd ed. Oxford, UK, Wiley-Blackwell; 2013:96-161.
Broadberry RE, Lin M. The incidence and significance of anti-“Mia” in Taiwan. Transfusion. 1994;34:349-52.
Palacajornsuk P, Nathalang O, Tantimavanich S, Bejrachandra S, Reid ME. Detection of MNS hybrid molecules in the Thai population using PCR-SSP technique. Transfus Med. 2007;17:169-74.
Jongruamklang P, Gassner C, Meyer S, Kummasook A, Darlison M, Boonlum C, et al. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry analysis of 36 blood group alleles among 396 Thai samples reveals region-specific variants. Transfusion. 2018;58:1752-62.
Poole J, King MJ, Mak KH, Liew YW, Leong S, Chua KM. The MiIII phenotype among Chinese donors in Hong Kong: immunochemical and serological studies. Transfus Med. 1991;1:169-75.
Hsu K, Lin YC, Chao HP, Lee TY, Lin M, Chan YS. Assessing the frequencies of GP.Mur (Mi.III) in several Southeast Asian populations by PCR typing. Transfus Apher Sci. 2013;49:370-1.
Huynh NT, Ford DS, Duyen TT, Huong MT. Jk and Mi.III phenotype frequencies in north Vietnam. Immunohematology. 2003;19:57-8..
Prathiba R, Lopez CG, Usin FM. The prevalence of GPMur and anti-“Mia” in a tertiary hospital in Peninsula Malaysia. Malaysian J Pathol. 2002;24:95-8.
Uchikawa M, Tsuneyama H, Akaza T, Tadokoro K, Juji T. Miltenberger antigens in Japanese. Book of Abstracts 6th Regional Congress of International Society of Blood Transfusion, Western Pacific Region; 1995:100. https://www.isbtweb.org/about-isbt/history?tx_isbtarchive_history%5B%40widget_0%5D%5BcurrentPage%5D=10&cHash=52ef7e8b0c1ab02887e40efe0738dc06
Race RR, Sanger R. The MNSs Blood Groups. Blood Groups in Man. 6-138. Oxford, Blackwell Scientific Publications LTD; 1975:92.
Lopez GH, Wlison B, Turner RM, Millard GM, Fraser NS, Roots NM, et al. Frequency of Mia (MNS7) and classification of Mia-positive hybrid glycophorins in an Australian blood donor population. Transfus Med Hemother. 2020;47:279-86.
Reid ME, Lisowska E, Blanchard D. Section 3: epitope determination of monoclonal antibodies to glycophorin A and glycophorin B. Coordinator’s report. Antibodies to antigens located on glycophorins and band 3. Transfus Clin Biol. 2002;9:63-72.
Tsuneyama H, Isa K, Watanabe-Okochi N, Ogasawara K, Uchikawa M, Satake M. An unusual variant glycophorin expressing protease-resistant M antigen encoded by the GYPB-E(2-4)-B hybrid gene. Vox Sang. 2020;115:579-85.
Rasamoelisolo M, Rahuel C, Loirat MJ, Willem C, Carron JP, Blanchard D. Immunochemical characterization of monoclonal antibodies directed to glycophorins A and/or B. Transfus Clin Biol. 1997;1:91-6.
Lyndall M. Intravascular hemolytic transfusion reaction due to anti-Vw+Mia with fatal outcome. Vox Sang. 1981;40:105-8.
Taylor AM, Knighton GJ. A case of severe hemolytic disease of the newborn due to anti-Verweyst (Vw). Transfusion. 1982;22:165-6.
Lin M, Broadberry RE. An intravascular hemolytic transfusion reaction due to anti-‘Mia’ in Taiwan. Vox Sang. 1994;67:320.
Lin CK, Mak KH, Cheng G, Lao TTH, Tang MHY, Yuen CMY. Serologic characteristics and clinical significance of Miltenberger antibodies among Chinese patients in Hong Kong. Vox Sang. 1998;74:59-60.
van den Bos AG, Steiner K. Haemolytic disease of the newborn caused by anti-MUT (MNS 35). Vox Sang. 2004;87:208-9.
Mallari RA, Chan A, Powers RJ, Pandipati S, Bensing KM, Biese D, et al. Fetal inheritance of GP*Mur causing severe HDFN in an unrecognized case of maternal alloimmunization. Transfusion. 2020;60:870-4.
Lomas-Francis C. Miltenberger phenotypes are glycophorin variants: a review. ISBT Sci Ser. 2011;6:296-301.
Broadberry RE, Lin M. The distribution of the MiIII (GP.Mur) phenotype among the population of Taiwan. Transfus Med. 1996;6:145-8.
Ellisor SS, Zelski D, Sugawara E, Dean WD, Bradburn S. A second example of anti-Hil. Transfusion. 1982;22:402.

Auteurs

Sayaka Kaito (S)

Japanese Red Cross Kanto-Koshinetsu Block Blood Center, Tokyo, Japan.

Yumi Suzuki (Y)

Japanese Red Cross Kanto-Koshinetsu Block Blood Center, Tokyo, Japan.

Atsuko Masuno (A)

Japanese Red Cross Kanto-Koshinetsu Block Blood Center, Tokyo, Japan.

Kazumi Isa (K)

Japanese Red Cross Central Blood Institute, Tokyo, Japan.

Chizu Toyoda (C)

Japanese Red Cross Kanto-Koshinetsu Block Blood Center, Tokyo, Japan.

Takayuki Onodera (T)

Japanese Red Cross Kanto-Koshinetsu Block Blood Center, Tokyo, Japan.

Kenichi Ogasawara (K)

Japanese Red Cross Central Blood Institute, Tokyo, Japan.

Makoto Uchikawa (M)

Japanese Red Cross Kanto-Koshinetsu Block Blood Center, Tokyo, Japan.

Nelson-Hirokazu Tsuno (NH)

Japanese Red Cross Kanto-Koshinetsu Block Blood Center, Tokyo, Japan.

Masahiro Satake (M)

Japanese Red Cross Central Blood Institute, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH